作者的详细信息

Fomina, Daria S.

期 栏目 标题 文件
卷 94, 编号 3 (2022) Original articles Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice PDF
(Rus)
卷 94, 编号 4 (2022) Original articles Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board PDF
(Rus)
卷 94, 编号 5 (2022) Original articles Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment PDF
(Rus)
卷 94, 编号 5 (2022) Original articles Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit PDF
(Rus)
卷 94, 编号 11 (2022) Original articles The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting PDF
(Rus)
卷 95, 编号 1 (2023) Original articles Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies PDF
(Rus)
卷 95, 编号 6 (2023) Original articles Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study PDF
(Rus)
卷 95, 编号 7 (2023) Original articles Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study) PDF
(Rus)
卷 95, 编号 8 (2023) Consensuns The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic PDF
(Rus)

##common.cookie##